Medical equipments

Tender description

NHS Wales Shared Services Partnership, on behalf of Cardiff and Vale University Health Board wish to inform the market that they intend to award a contract for the supply, installation and 5 years maintenance (including warranty) of one Illumina NextSeq, next-generation sequencing (NGS) instruments, (With an option to increase the order to 2 units subject to funding availability) for the Medical Genetics Department. The contract will include training, installation and integration into IT services. NHS Wales Shared Services Partnership, on behalf of Cardiff and Vale University Health Board wish to inform the market that they intend to award a contract for the supply, installation and 5 years maintenance (including warranty) of an Illumina NextSeq, next-generation sequencing (NGS) instrument, (with an option for a second instrument of the same spec subject to funding availablility) for the Medical Genetics Department. The contract will include training, installation and integration into IT services. Funding has been approved by Welsh Government to support the procurement of additional NGS sequencers. The laboratory has two Illumina MiSeq Sequencers and an Illumina HiSeq 2500 currently in service, they are well embedded within the laboratories services for sequencing a number of different targeted NGS panels and an exome panel. Demand is increasing for the NGS workload, due to benefits in efficiency and cost of the testing. To change from the current Illumina platform would mean revalidation of all current protocols at a significant cost to the laboratory which would impact on current throughput and subsequently patient care.